Robert Norton, DPM
Foot Surgery · Philadelphia, PANPI 1063907210
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,899 of the $3,867 with a category attached, or 75.0%. 19 manufacturers reported payments, led by Smith+Nephew at 36.3% of the total. Reporting peaked in 2023 at $1,826 and has fallen 60.3% since, to $726 in 2025. Among foot surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $39.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Medical Device Business Services, Inc.$1K
- Stryker$232
- Johnson & Johnson$224
- Globus Medical$184
- Paratek Pharmaceuticals, Inc.$111
- plus $567 from 13 others
What the payments were for
- Travel & lodging$96825%
- Food & beverage$2,89975%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 50 | $1,403 |
| Medical Device Business Services, Inc. | 7 | $1,146 |
| Stryker | 5 | $232 |
| Johnson & Johnson | 6 | $224 |
| Globus Medical | 1 | $184 |
| Paratek Pharmaceuticals, Inc. | 6 | $111 |
| Kerecis Limited | 1 | $86 |
| AbbVie | 4 | $80 |
| Lifenet Health | 5 | $63 |
| Kuros Biosciences USA, Inc | 1 | $62 |
| KCI USA, Inc. | 2 | $48 |
| Orthofix Medical, Inc. | 2 | $44 |
| Bioventus LLC | 1 | $39 |
| Solventum Corporation | 1 | $35 |
| Acera Surgical, Inc. | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $25 |
| Organogenesis Inc. | 1 | $24 |
| Next Science LLC | 1 | $21 |
| Carbofix Orthopedics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Excelsius3D Imaging System$184
- GRAFIX PL$147
- Oasis$147
- Stravix$147
How this compares
$3,867 in reported general payments places this provider in the 95th percentile of 67 foot surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 31 | $38,654 |
| Ciclopirox | 24 | $581 |
| Gabapentin | 20 | $439 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $308 |
| Ammonium Lactate | 13 | $195 |
| Ciprofloxacin Hcl | 11 | $123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,403 | $38,65431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 67 foot surgery providers in Pennsylvania.
Other foot surgery in Philadelphia
- Ronald SmallPhiladelphia$2K
- Faramarz FanaianPhiladelphia$933
- Susan GamblePhiladelphia$633
- Josephine DepalmaPhiladelphia$534
- Ira SilvermanPhiladelphia$418
- Karen GalliPhiladelphia$60
- Donna MyersPhiladelphia$52
- Joshua ScollBensalem$18K
- Derrico QuattroneJefferson Hills$6K
- Dawn SteinGrove City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.